USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Mar 14, 2022 | Dec 2021 | $0.11 | $0.10 | $0.11 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Mar 14, 2022 | Dec 2021 | $36.90M | $35.95M | $31.01M |
Catalyst Pharmaceuticals's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $0.11 | $0.10 | $0.12 |
| Mar 2022 | 3 | $0.11 | $0.10 | $0.12 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $0.39 | $0.38 | $0.41 |
| Dec 2022 | 5 | $0.50 | $0.44 | $0.61 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 3 / 1 | $0.11 | $0.11 | $0.09 |
| Mar 2022 | 0 / 1 | $0.16 | $0.16 | $0.12 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 3 / 1 | $0.39 | $0.39 | $0.39 |
| Dec 2022 | 2 / 1 | $0.56 | $0.55 | $0.43 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $36.90M | $36.25M | $37.91M |
| Mar 2022 | 3 | $38.26M | $38.00M | $38.66M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $137.74M | $135.98M | $139.38M |
| Dec 2022 | 5 | $164.18M | $156.25M | $175.71M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 14, 2022 | Dec 2021 | $0.11 | - | - |
| Nov 9, 2021 | Sep 2021 | $0.10 | $0.10 | -3.85% |
| Aug 9, 2021 | Jun 2021 | $0.10 | $0.11 | 13.75% |
| May 10, 2021 | Mar 2021 | $0.09 | $0.07 | -18.60% |
| Mar 15, 2021 | Dec 2020 | $0.09 | $0.11 | 22.22% |
| Nov 9, 2020 | Sep 2020 | $0.10 | $0.41 | 327.08% |
| Aug 10, 2020 | Jun 2020 | $0.09 | $0.09 | 5.88% |
| May 11, 2020 | Mar 2020 | $0.09 | $0.10 | 15.34% |
| Mar 16, 2020 | Dec 2019 | $0.10 | $0.07 | -32.24% |
| Nov 12, 2019 | Sep 2019 | $0.11 | $0.13 | 14.04% |
| Aug 7, 2019 | Jun 2019 | $0.03 | $0.10 | 263.64% |
| May 10, 2019 | Mar 2019 | $-0.11 | $-0.01 | 90.91% |
| Mar 18, 2019 | Dec 2018 | $-0.12 | $-0.14 | -21.74% |
| Nov 7, 2018 | Sep 2018 | $-0.08 | $-0.08 | -6.67% |
| Aug 7, 2018 | Jun 2018 | $-0.08 | $-0.06 | 20.00% |
| May 9, 2018 | Mar 2018 | $-0.06 | $-0.06 | - |
| Mar 14, 2018 | Dec 2017 | $-0.06 | $-0.06 | - |
| Nov 8, 2017 | Sep 2017 | $-0.06 | $-0.05 | 9.09% |
| Aug 9, 2017 | Jun 2017 | $-0.06 | $-0.05 | 20.00% |
| May 10, 2017 | Mar 2017 | $-0.06 | $-0.06 | - |
| Mar 15, 2017 | Dec 2016 | $-0.07 | $-0.05 | 25.93% |
| Nov 9, 2016 | Sep 2016 | $-0.06 | $-0.05 | 16.67% |
| Aug 9, 2016 | Jun 2016 | $-0.08 | $-0.06 | 20.00% |
| May 10, 2016 | Mar 2016 | $-0.07 | $-0.07 | -4.95% |
| Mar 15, 2016 | Dec 2015 | $-0.07 | $-0.07 | -3.70% |
| Nov 9, 2015 | Sep 2015 | $-0.07 | $-0.05 | 28.57% |
| Aug 10, 2015 | Jun 2015 | $-0.07 | $-0.06 | 14.29% |
| May 11, 2015 | Mar 2015 | $-0.09 | $-0.07 | 22.22% |
| Mar 16, 2015 | Dec 2014 | $-0.07 | $-0.05 | 28.57% |
| Nov 13, 2014 | Sep 2014 | $-0.05 | $-0.07 | -40.00% |
| Aug 13, 2014 | Jun 2014 | $-0.07 | $-0.05 | 28.57% |
| May 15, 2014 | Mar 2014 | $-0.06 | $-0.07 | -16.67% |
| Mar 19, 2014 | Dec 2013 | $-0.07 | $-0.02 | 71.43% |
| Nov 14, 2013 | Sep 2013 | $-0.07 | $-0.13 | -85.71% |
| Aug 15, 2013 | Jun 2013 | $-0.06 | $-0.08 | -33.33% |
| Apr 2, 2013 | Mar 2013 | $-0.09 | $-0.04 | 55.56% |
| Nov 15, 2012 | Sep 2012 | $-0.03 | $-0.08 | -166.67% |
| Aug 15, 2012 | Jun 2012 | $-0.04 | $-0.01 | 75.00% |
| Apr 2, 2012 | Mar 2012 | $-0.06 | $-0.10 | -66.67% |
| Nov 15, 2011 | Sep 2011 | $-0.07 | $-0.05 | 28.57% |
| Aug 16, 2011 | Jun 2011 | $-0.08 | $-0.06 | 25.00% |
| Apr 1, 2011 | Mar 2011 | $-0.07 | $-0.04 | 42.86% |
| Mar 31, 2011 | Dec 2010 | $-0.07 | $-0.04 | 42.86% |
| Nov 16, 2010 | Sep 2010 | $-0.08 | $-0.05 | 37.50% |
| Aug 13, 2010 | Jun 2010 | $-0.07 | $-0.07 | - |
| Apr 1, 2010 | Mar 2010 | $-0.05 | $-0.06 | -20.00% |
| Mar 31, 2010 | Dec 2009 | $-0.05 | $-0.06 | -20.00% |
| Nov 12, 2009 | Sep 2009 | $-0.10 | $-0.09 | 10.00% |
| Aug 7, 2009 | Jun 2009 | $-0.20 | $-0.13 | 35.00% |
| May 14, 2009 | Mar 2009 | $-0.24 | $-0.22 | 8.33% |
| Mar 26, 2009 | Dec 2008 | $-0.23 | $-0.27 | -17.39% |
| Nov 14, 2008 | Sep 2008 | $-0.23 | $-0.22 | 4.35% |
| Aug 15, 2008 | Jun 2008 | - | $-0.19 | - |
| May 16, 2008 | Mar 2008 | $-0.12 | $-0.13 | -8.33% |
| Mar 26, 2008 | Dec 2007 | $-0.07 | $-0.08 | -14.29% |
| Nov 14, 2007 | Sep 2007 | $-0.16 | $-0.06 | 62.50% |
| Aug 10, 2007 | Jun 2007 | $-0.14 | $-0.10 | 28.57% |
| Apr 2, 2007 | Mar 2007 | $-0.07 | $-0.07 | - |
| Dec 16, 2006 | Sep 2006 | - | $-0.27 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 15, 2021 | Dec 2020 | $0.69 | $0.71 | 2.90% |
| Mar 16, 2020 | Dec 2019 | $0.33 | $0.29 | -12.12% |
| Mar 18, 2019 | Dec 2018 | $-0.31 | $-0.34 | - |
| Mar 14, 2018 | Dec 2017 | $-0.22 | $-0.22 | - |
| Mar 15, 2017 | Dec 2016 | - | $-0.23 | - |
| Mar 15, 2016 | Dec 2015 | - | $-0.25 | - |
| Mar 16, 2015 | Dec 2014 | - | $-0.24 | - |
| Mar 19, 2014 | Dec 2013 | - | $-0.61 | - |
| Mar 31, 2011 | Dec 2010 | - | $-0.22 | - |
| Mar 31, 2010 | Dec 2009 | - | $-0.50 | - |
| Mar 26, 2009 | Dec 2008 | - | $-0.81 | - |
| Mar 26, 2008 | Dec 2007 | - | $-0.58 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 14, 2022 | Dec 2021 | $36.90M | - | - |
| Nov 9, 2021 | Sep 2021 | $34.59M | $35.95M | 1.04% |
| Aug 9, 2021 | Jun 2021 | $36.37M | $36.37M | 1.00% |
| May 10, 2021 | Mar 2021 | $32.10M | $30.20M | 0.94% |
| Mar 15, 2021 | Dec 2020 | $30.35M | $31.01M | 1.02% |
| Nov 9, 2020 | Sep 2020 | $31.49M | $29.32M | 0.93% |
| Aug 10, 2020 | Jun 2020 | $29.48M | $29.60M | 1.00% |
| May 11, 2020 | Mar 2020 | $31.46M | $29.14M | 0.93% |
| Mar 16, 2020 | Dec 2019 | $29.40M | $30.12M | 1.02% |
| Nov 12, 2019 | Sep 2019 | $33.18M | $30.90M | 0.93% |
| Aug 7, 2019 | Jun 2019 | $18.49M | $28.84M | 1.56% |
| May 10, 2019 | Mar 2019 | $1.60M | $12.45M | 7.78% |
| Mar 18, 2019 | Dec 2018 | $0.00 | $500.00K | - |
| Nov 7, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 7, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| May 9, 2018 | Mar 2018 | $0.00 | $0.00 | - |
| Mar 14, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Nov 8, 2017 | Sep 2017 | $0.00 | $0.00 | - |
| Aug 9, 2017 | Jun 2017 | $0.00 | $0.00 | - |
| May 10, 2017 | Mar 2017 | - | $0.00 | - |
| Mar 15, 2017 | Dec 2016 | - | $0.00 | - |
| Nov 9, 2016 | Sep 2016 | - | $0.00 | - |
| Aug 9, 2016 | Jun 2016 | - | $0.00 | - |
| May 10, 2016 | Mar 2016 | - | $0.00 | - |
| Mar 15, 2016 | Dec 2015 | - | $0.00 | - |
| Nov 9, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 10, 2015 | Jun 2015 | - | $0.00 | - |
| May 11, 2015 | Mar 2015 | - | $0.00 | - |
| Mar 16, 2015 | Dec 2014 | - | $0.00 | - |
| Nov 13, 2014 | Sep 2014 | - | $0.00 | - |
| Aug 13, 2014 | Jun 2014 | - | $0.00 | - |
| May 15, 2014 | Mar 2014 | - | $0.00 | - |
| Mar 19, 2014 | Dec 2013 | - | $0.00 | - |
| Nov 14, 2013 | Sep 2013 | - | $0.00 | - |
| Aug 15, 2013 | Jun 2013 | - | $0.00 | - |
| Apr 2, 2013 | Mar 2013 | - | $0.00 | - |
| Nov 15, 2012 | Sep 2012 | - | $0.00 | - |
| Aug 15, 2012 | Jun 2012 | - | $0.00 | - |
| Apr 2, 2012 | Mar 2012 | - | $0.00 | - |
| Nov 15, 2011 | Sep 2011 | - | $0.00 | - |
| Aug 16, 2011 | Jun 2011 | - | $0.00 | - |
| Apr 1, 2011 | Mar 2011 | - | $488.96K | - |
| Mar 31, 2011 | Dec 2010 | - | $488.96K | - |
| Nov 16, 2010 | Sep 2010 | - | $0.00 | - |
| Aug 13, 2010 | Jun 2010 | - | $0.00 | - |
| Apr 1, 2010 | Mar 2010 | - | $0.00 | - |
| Mar 31, 2010 | Dec 2009 | - | $0.00 | - |
| Nov 12, 2009 | Sep 2009 | - | $0.00 | - |
| Aug 7, 2009 | Jun 2009 | - | $0.00 | - |
| May 14, 2009 | Mar 2009 | - | $0.00 | - |
| Mar 26, 2009 | Dec 2008 | - | $0.00 | - |
| Nov 14, 2008 | Sep 2008 | - | $0.00 | - |
| Aug 15, 2008 | Jun 2008 | - | $0.00 | - |
| May 16, 2008 | Mar 2008 | - | $0.00 | - |
| Mar 26, 2008 | Dec 2007 | - | $0.00 | - |
| Nov 14, 2007 | Sep 2007 | - | $0.00 | - |
| Aug 10, 2007 | Jun 2007 | - | $0.00 | - |
| Apr 2, 2007 | Mar 2007 | - | $0.00 | - |
| Dec 16, 2006 | Sep 2006 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 15, 2021 | Dec 2020 | $118.35M | $119.07M | 0.61% |
| Mar 16, 2020 | Dec 2019 | $101.58M | $102.31M | 0.72% |
| Mar 18, 2019 | Dec 2018 | $0.00 | $500.00K | - |
| Mar 14, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Mar 15, 2017 | Dec 2016 | - | $0.00 | - |
| Mar 15, 2016 | Dec 2015 | - | $0.00 | - |
| Mar 16, 2015 | Dec 2014 | - | $0.00 | - |
| Mar 19, 2014 | Dec 2013 | - | $0.00 | - |
| Mar 31, 2011 | Dec 2010 | - | $488.96K | - |
| Mar 31, 2010 | Dec 2009 | - | - | - |
| Mar 26, 2009 | Dec 2008 | - | - | - |
| Mar 26, 2008 | Dec 2007 | - | - | - |
CPRX's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 31, 2021.
According to 5 analysts, the average EPS estimation for Catalyst Pharmaceuticals's next quarterly earnings is $0.11, with a low EPS estimation of $0.10, and a high estimation of $0.12.
Over the last 1 month, EPS estimates have seen 3 upward revisions and 1 downward. The EPS 1 month trend is $0.11, the last 2 month trend is $0.11, and the 3 month trend is $0.09.
Based on 5 analysts, the average revenue estimation is $36.90M, with a low revenue estimation of $36.25M, and a high estimation of $37.91M.
Catalyst Pharmaceuticals's previous earnings date was Nov 9, 2021 for its fiscal quarter ended Sep 30, 2021.
CPRX's earnings per share (EPS) was $0.10, missing the consensus analysts forecast of $0.10 by -3.85%.
The EPS was lower than the previous fiscal quarter (Jun 2021) by -9.09%, and lower than the same period a year before (Sep 2020) by -75.61%.
Revenues were $35.95M, better than the forecast of $34.59M by 3.94%, down by -1.13% from the previous quarter , and up by 22.64% from the same period last year.
The company reported a net income of $10.33M, -15.20% lower than the previous quarter, and lower by -76.17% than the same period a year before.
Free cash flow for the quarter was $21.64M , compared to $15.67M last quarter and $11.44M a year before.
CPRX ended the quarter with $7.95M in total debt, an increase of 86.92% compared to the previous quarter, and an increase of 6835.92% compared to the same quarter a year before.
Catalyst Pharmaceuticals's previous annual earnings date was Mar 15, 2021 for its fiscal year ended Dec 31, 2020.
CPRX's earnings per share (EPS) was $0.71, beating the consensus analysts forecast of $0.69 by 2.90% , and higher than the previous year's EPS (Dec 2019) by 144.83%.
Revenues were $119.07M, better than the forecast of $118.35M by 0.61%, and up by 16.39% from previous year's revenue.
The company reported a net income of $74.98M, 135.24% higher than the previous year.
Catalyst Pharmaceuticals reported a free cash flow of $45.02M for its fiscal year, compared to $34.59M a year ago.
The company ended the fiscal year with $28.77K in total debt, a decrease of -96.97% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
